GenieBiome Limited
PrivateLast Round
Series B
Nov 1, 2021
Company Overview
GenieBiome Limited operates in Healthcare & Life Sciences and is based in Hong Kong. Its latest recorded funding round was a Series B round in November 2021.
GenieBiome Limited is a biotechnology company that develops microbiome-based diagnostics and personalized therapeutic solutions for various diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Precision Medicine, Clinical Trials, Drug Discovery
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenieBiome Limited Comparables
Compare GenieBiome Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AMILI | 82% | |
| Leucine Rich Bio | 79% | |
| Floré | 78% |
For institutional investors. Book with your work email.
GenieBiome Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 1, 2021 | ||||
| Series A | Aug 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenieBiome Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beyond Ventures | Series A |
| The Chinese University of Hong Kong | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 179% MoM, reaching 2.2K.
- May 15, 2026
Monthly visitors grew 1234% MoM, from 59 to 787.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asOct 20, 2026
Geniebiome, a biotechnology spinout from The Chinese University of Hong Kong, is named one of only eight inaugural New Industrialisation Elite Enterprises by the Innovation, Technology and Industry Bureau of the Government of the Hong Kong Special Administrative Region on Oct 20th '26 in Hong Kong.
For institutional investors. Book with your work email.
GenieBiome Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenieBiome Limited's valuation, stock price, and market status.
Is GenieBiome Limited a public or private company?
GenieBiome Limited is a private company.
What is the current stock price of GenieBiome Limited?
GenieBiome Limited is a private company, so its shares have no public market price. Caplight tracks GenieBiome Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenieBiome Limited worth (valuation)?
Valuation information for GenieBiome Limited is not publicly available.
Can I buy GenieBiome Limited stock?
GenieBiome Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenieBiome Limited's last funding round?
GenieBiome Limited's most recent funding round was Series B on November 1, 2021.
Who are the main investors in GenieBiome Limited?
Key investors in GenieBiome Limited include Beyond Ventures, The Chinese University of Hong Kong.
Will GenieBiome Limited IPO soon?
No public IPO plans have been announced for GenieBiome Limited.
How can I track GenieBiome Limited secondary market activity?
Caplight tracks bids, offers, and trades in GenieBiome Limited's shares on secondary markets.